Interleukin-10-based therapy for inflammatory bowel disease.
about
Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector.Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin.Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease.Role of interleukin 10 transcriptional regulation in inflammation and autoimmune diseaseEffects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitisBilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis.Novel drug delivery strategies for the treatment of inflammatory bowel disease.Delivery of therapeutic proteins to the mucosa using genetically modified microflora.Therapeutic drug delivery by genetically modified Lactococcus lactis.Recent understanding of IBD pathogenesis: implications for future therapies.Inflammatory bowel disease-related arthritis - clinical evaluation and possible role of cytokines.CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation.Why interleukin-10 supplementation does not work in Crohn's disease patients.Delivery strategies to control inflammatory response: Modulating M1-M2 polarization in tissue engineering applications.Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis.Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.
P2860
Q24812028-861B9F12-32AC-43F5-B02D-14162B5AA0A7Q33307618-8FD03E43-5209-4E20-858C-A74E16A0652FQ33960092-8BFCBC49-E379-4EE4-A309-8E77F6563F7DQ34262223-2E113A2E-DE64-48E7-BA6A-CBFF613CFDBDQ35062006-4F9CCFAE-07C1-43AA-9563-B323F891D5C3Q36010505-438B9A1C-656B-4700-A2FB-436A8093C5FFQ36316765-189F055A-C97B-498C-83FA-89B64446D563Q36316890-A902E074-F020-4B5E-97F5-0B976D784C6AQ36631447-A8A4943F-1B36-4949-8F4A-C0070C94154EQ36639759-7A345C1B-C8B9-4ED8-85F9-39FD0F8406A6Q36842484-38342A0F-ED37-49BC-B242-703F359BD52AQ37227202-FA13440B-5191-43EB-BE37-D8BDA3981F0CQ38120519-6951CB0C-B787-4DD8-BEF8-5BF497E8AE2DQ38700498-EC2FFE5F-A52C-460C-8DA5-C0838912B2AEQ42223966-E1EFD7CD-FE7A-4B33-B037-B5A28CE91755Q42944296-7865B5F0-8C37-44B0-B0C3-16C3699C0399Q52653104-828BF20F-A4D4-467F-A44C-A3199E505822Q55519564-02B521AA-9920-47A4-8675-0878AC19B925
P2860
Interleukin-10-based therapy for inflammatory bowel disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interleukin-10-based therapy for inflammatory bowel disease.
@ast
Interleukin-10-based therapy for inflammatory bowel disease.
@en
type
label
Interleukin-10-based therapy for inflammatory bowel disease.
@ast
Interleukin-10-based therapy for inflammatory bowel disease.
@en
prefLabel
Interleukin-10-based therapy for inflammatory bowel disease.
@ast
Interleukin-10-based therapy for inflammatory bowel disease.
@en
P2860
P356
P1476
Interleukin-10-based therapy for inflammatory bowel disease.
@en
P2093
Daan W Hommes
P2860
P304
P356
10.1517/14712598.3.5.725
P407
P577
2003-08-01T00:00:00Z